Since over activity of GSK3β impairs neurogenesis (and neuron migration; Kim and Snider, 2011), the APP-AICD-mediated increase in GSK3β activity is expected to impair proliferation in the fetal DS brain. The gene discussed is GSK3B; the disease is Dravet syndrome.